Status: Recruiting
Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients
The goal of this study is to see how an ingredient called kynurenic acid (which we named "FS2") affects scar formation in people with burn injuries that need skin graft surgery. A cream with FS2 will be used on both the area where the skin graft was placed and the area where the skin was taken (donor site). The cream will be applied after the skin has healed. This study will help us understand if FS2 is safe and effective for mitigating skin scar formation in burn patients.
Participants needed: 70
Trial details
Phase: Phase 2, Phase 3Age: 12-65Biological sex: AllType: InterventionalSponsor: Birch BioMed IncUpdated: May 4, 2026Locations: 2
Eligibility criteria
Medically able and willing to consent/assent to study requirements [+9]
Medically unable to consent to study requirements [+17]